Clinical and Research Safety Data Personal Peptide Safety: CJC-1295 without DAC has been studied in clinical trials and shows good tolerability with minimal adverse effects at research doses, no major effects on cortisol or prolactin, good safety profile across dose ranges, and no serious adverse events in research studies
Despite the higher price, we believe that injections offer better value to patients due to the far superior absorption and their effectiveness in contributing to better health and wellbeing
Shorten the cycle if: results have plateaued for 2+ weeks despite dose optimization, you are experiencing fatigue or other signs of potential receptor desensitization, or your goals have been achieved before the planned cycle end
Use acetic acid water (typically 0.6%) when a peptide will not fully dissolve in plain bacteriostatic water
Myth- Alcohol is not a drug
Avoid Research Chemicals : Unapproved peptides can lead to unpredictable results and unwanted side effects